Article

Mmarketwatch.com on 2018-11-26 13:20

GW Pharma announces positive results from another trial of cannabis-based treatment for childhood epilepsy

Philip M. Gattone

Related news

MGW Pharma gets EU approval for cannabis-based drug as treatment for severe childhood epilepsy marketwatch.com
Europe
BSales Keep Growing for GW Pharma’s Cannabis-Based Epilepsy Treatment barrons.com
Wall Street , Sittingbourne
MGW Pharma shares rise after UK recommends NHS reimburse its CBD-based epilepsy drug marketwatch.com
Europe , France
Cannabis Drug Succeeds in Epilepsy, Doubling Value of GW Pharma infowars.com
MGW Pharma shares rally on earnings and news of late-stage trial of cannabis-based treatment for MS patients marketwatch.com
Australia , Spain , Italy , France , Germany
MMarijuana-derived epilepsy drug doubles sales, sending GW Pharma stock soaring marketwatch.com
MMarijuana-derived epilepsy-drug sales rise 25%, but GW Pharma stock plunges more than 12%marketwatch.com
San Francisco , Germany , France
Marijuana-Based Drug Nears Approval For Childhood Epilepsy infowars.com
MGW Pharma initiated at Leerink with 'outperform' rating marketwatch.com
Jazz Pharmaceuticals to Buy GW Pharma for $6.7 Billion wsj.com
UHealth Launches New Deep Brain Stimulation Treatment for Epilepsy communitynewspapers.com
Miami , South Florida , United States , Florida
UHealth launches new deep brain stimulation treatment for epilepsy communitynewspapers.com
Miami , South Florida , United States , Florida
Sponsored Content: Local treatment, local options from epilepsy unit The Daily Sentinel
United States , Colorado's Western Slope , Grand Junction , Billings , Denver
MGW Pharmaceuticals sells more of CBD-derived epilepsy drug than expected, stock rises marketwatch.com
Wall Street
8-year-old Irish girl with severe epilepsy now pharma free thanks to medicinal marijuana treatment irishpost.com
Netherlands , Dublin , Cork , Aghabullogue , Ireland
Bill makes cannabis-based medicine for childhood epilepsy legal in California The Press Democrat
Santa Rosa , California
MGW Pharma shares surge on FDA briefing document that hints at approval of cannabis-derived drug marketwatch.com
GWPH Stock Forecast: FDA Can Change the Fate for GW Pharma—and Marijuana Stocks?profitconfidential.com
Europe
MOPpenheimer lowers GW Pharma price target, tweaks revenue forecasts for Epidiolex marketwatch.com
MGW Pharma shares soar 9% premarket as Oppenheimer upgrades to outperform marketwatch.com